title: State of the art in tumor antigen and biomarker discovery.
abstract: Our knowledge of tumor immunology has resulted in multiple approaches for the treatment of cancer. However, a gap between research of new tumors markers and development of immunotherapy has been established and very few markers exist that can be used for treatment. The challenge is now to discover new targets for active and passive immunotherapy. This review aims at describing recent advances in biomarkers and tumor antigen discovery in terms of antigen nature and localization, and is highlighting the most recent approaches used for their discovery including "omics" technology.
authors.affiliation: INSERM U624, 163 avenue de Luminy, 13288 Marseille Cedex 09, France. :patrick.chames@inserm.fr.
authors.forename: Klervi
authors.initials: K
authors.lastname: Even-Desrumeaux
authors.forename: Daniel
authors.initials: D
authors.lastname: Baty
authors.forename: Patrick
authors.initials: P
authors.lastname: Chames